These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1665791)

  • 1. Transcainide: biochemical evidence for state-dependent interaction with the class I antiarrhythmic drug receptor.
    Hill RJ; Thakore E; Taouis M; Duff HJ; Sheldon RS
    Eur J Pharmacol; 1991 Oct; 203(1):51-8. PubMed ID: 1665791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class I antiarrhythmic drug receptor: biochemical evidence for state-dependent interaction with quinidine and lidocaine.
    Hill RJ; Duff HJ; Sheldon RS
    Mol Pharmacol; 1989 Jul; 36(1):150-9. PubMed ID: 2546048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class I antiarrhythmic drugs: allosteric inhibitors of [3H] batrachotoxinin binding to rat cardiac sodium channels.
    Sheldon RS; Duff HJ; Thakore E; Hill RJ
    J Pharmacol Exp Ther; 1994 Jan; 268(1):187-94. PubMed ID: 8301556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A receptor for type I antiarrhythmic drugs associated with rat cardiac sodium channels.
    Sheldon RS; Cannon NJ; Duff HJ
    Circ Res; 1987 Oct; 61(4):492-7. PubMed ID: 2443266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone: biochemical evidence for binding to a receptor for class I drugs associated with the rat cardiac sodium channel.
    Sheldon RS; Hill RJ; Cannon NJ; Duff HJ
    Circ Res; 1989 Aug; 65(2):477-82. PubMed ID: 2546697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dilazep inhibits binding of batrachotoxin to sodium channels in canine sarcolemmal vesicles.
    Chiba K; Hashizume H; Inagaki SI; Abiko Y
    Arch Int Pharmacodyn Ther; 1995; 330(2):138-50. PubMed ID: 8861708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by propofol of [3H]-batrachotoxinin-A 20-alpha-benzoate binding to voltage-dependent sodium channels in rat cortical synaptosomes.
    Ratnakumari L; Hemmings HC
    Br J Pharmacol; 1996 Dec; 119(7):1498-504. PubMed ID: 8968561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of binding of [3H]batrachotoxinin A 20-alpha-benzoate to sodium channels by local anesthetics.
    Postma SW; Catterall WA
    Mol Pharmacol; 1984 Mar; 25(2):219-27. PubMed ID: 6321944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcainide causes two modes of open-channel block with different voltage sensitivities in batrachotoxin-activated sodium channels.
    Zamponi GW; French RJ
    Biophys J; 1994 Sep; 67(3):1028-39. PubMed ID: 7811913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoalkyl structural requirements for interaction of lidocaine with the class I antiarrhythmic drug receptor on rat cardiac myocytes.
    Sheldon RS; Hill RJ; Taouis M; Wilson LM
    Mol Pharmacol; 1991 May; 39(5):609-14. PubMed ID: 1851959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereospecific interaction of tocainide with the cardiac sodium channel.
    Sheldon RS; Cannon NJ; Nies AS; Duff HJ
    Mol Pharmacol; 1988 Mar; 33(3):327-31. PubMed ID: 2451117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of [3H]batrachotoxinin A benzoate to specific sites on rat cardiac sodium channels.
    Sheldon RS; Cannon NJ; Duff HJ
    Mol Pharmacol; 1986 Dec; 30(6):617-23. PubMed ID: 2431264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of sodium channel gene expression by class I antiarrhythmic drugs and n - 3 polyunsaturated fatty acids in cultured neonatal rat cardiac myocytes.
    Kang JX; Li Y; Leaf A
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2724-8. PubMed ID: 9122264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic AMP-dependent regulation of the number of [3H]batrachotoxinin benzoate binding sites on rat cardiac myocytes.
    Taouis M; Sheldon RS; Hill RJ; Duff HJ
    J Biol Chem; 1991 Jun; 266(16):10300-4. PubMed ID: 1645346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of stereospecific binding of type I antiarrhythmic drugs to cardiac sodium channels.
    Hill RJ; Duff HJ; Sheldon RS
    Mol Pharmacol; 1988 Nov; 34(5):659-63. PubMed ID: 2848186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium channel block by a potent, new antiarrhythmic agent, transcainide, in guinea pig ventricular myocytes.
    Bennett PB; Stroobandt R; Kesteloot H; Hondeghem LM
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):661-7. PubMed ID: 2442531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kavain, dihydrokavain, and dihydromethysticin non-competitively inhibit the specific binding of [3H]-batrachotoxinin-A 20-alpha-benzoate to receptor site 2 of voltage-gated Na+ channels.
    Friese J; Gleitz J
    Planta Med; 1998 Jun; 64(5):458-9. PubMed ID: 9690349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a common site of action of lidocaine and carbamazepine in voltage-dependent sodium channels.
    Zimányi I; Weiss SR; Lajtha A; Post RM; Reith ME
    Eur J Pharmacol; 1989 Aug; 167(3):419-22. PubMed ID: 2553444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of sodium channels and inhibition of [3H]batrachotoxinin A-20-alpha-benzoate binding by an N-alkylamide neurotoxin.
    Ottea JA; Payne GT; Bloomquist JR; Soderlund DM
    Mol Pharmacol; 1989 Aug; 36(2):280-4. PubMed ID: 2549384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of yohimbine with batrachotoxinin binding to mouse brain sodium channels.
    Zimanyi I; Lajtha A; Vizi ES; Reith ME
    Biochem Pharmacol; 1988 Feb; 37(4):641-5. PubMed ID: 2449217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.